Form 4: Marimed COO Timothy Shaw Converts RSUs, Adjusts Holdings

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, converted 111,112 Restricted Stock Units into common stock and subsequently disposed of 32,612 shares for tax obligations.

Summary

• Timothy Shaw, Chief Operating Officer of Marimed Inc., reported changes in his beneficial ownership of company common stock.
• On October 27, 2025, 111,112 Restricted Stock Units (RSUs) vested and converted into shares of common stock on a one-for-one basis.
• Concurrently, 32,612 shares of common stock were withheld by Marimed Inc. to satisfy tax withholding obligations related to the RSU vesting.
• The shares withheld for tax purposes were valued at $0.1579 per share.
• Following these transactions, Mr. Shaw directly beneficially owns 9,133,912 shares of common stock.
• He also indirectly beneficially owns 2,000,000 shares through The Shaw Family Trust, for which he disclaims beneficial ownership.
• All RSUs granted on October 27, 2022, have now fully vested, with no unvested RSUs remaining under that specific grant.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and tax-related share disposition, which is neutral in sentiment.

Positives

• Vesting of 111,112 Restricted Stock Units (RSUs) indicates the achievement of performance or tenure milestones by the Chief Operating Officer.
• The conversion of RSUs into common stock aligns the COO's interests with those of shareholders.
• The RSU grant from October 27, 2022, is now fully vested, indicating successful completion of the award terms.

Negatives

• 32,612 shares of common stock were disposed of to satisfy tax withholding obligations, reducing the direct beneficial ownership.

Risks

• No specific risks are detailed in this Form 4 filing, as it primarily reports a routine insider transaction.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• No notable quotes or paraphrased statements from company management are included in this Form 4 filing.

Industry Context

This Form 4 filing reports a routine insider transaction (RSU vesting and tax-related share disposition) and does not provide information relevant to broader industry trends or competitor analysis.

Comparison to Industry Standards

• This Form 4 filing reports a routine insider transaction and does not contain information suitable for comparison to global benchmarks or specific comparable companies/projects.

Related Party Transactions

• The filing notes indirect beneficial ownership of 2,000,000 shares through The Shaw Family Trust, where the reporting person's spouse is the trustee and the shares are for the benefit of the reporting person's children. The reporting person disclaims beneficial ownership of these securities.

Stakeholder Impact

• Minimal impact on shareholders, as this is a routine insider transaction. It provides transparency regarding executive compensation and ownership structure.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

Marimed Inc., MRMD, Timothy Shaw, Chief Operating Officer, COO, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Common Stock, Beneficial Ownership, Tax Withholding